Atlas Trials

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.

Clinical trial NCT05145348 · UNKNOWN

Trial details

NCT number
NCT05145348
Sponsor
UMC Utrecht
Status
UNKNOWN
Study type
OBSERVATIONAL
Down SyndromeSARS-CoV-2 Vaccination
Start date
2021-02-03
Primary completion
2022-06-30
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.